Lanly Bioscience
Current position:
Homologous xenograft model

In vivo pharmacology

Homologous xenograft model


Tumor immune drugs mainly use drugs to mediate a sound immune system to attack tumors to achieve tumor suppression. Therefore, in preclinical animal pharmacodynamic experiments, it is necessary to use mice with normal immune systems to inoculate homologous tumor cells to establish homology. Transplanted tumor model.

Tuowei's established homologous xenograft models include:

Breast cancer model: 4T-1a

Colon cancer model: CT-26; MC-38

Kidney tumor model: Renca

Liver cancer model: H22; Hepa 1-6

Melanoma model: B16F10

Pancreatic cancer model: PanC02

Scan the QR code to read on your phone

Contact Us

Time of issue:2021-03-22 16:58:53

Address:99 Mengxi Road, Shaxi Town, Taicang City, Jiangsu Province

Time of issue:2021-03-22 17:01:27

Lanly Bioscience
Scan code to browse

Time of issue:2021-03-22 16:00:55

Copyright:Lanly Bioscience Technology (Suzhou) Co., Ltd. | Copyright - 2021 All Rights Reserved.       苏ICP备2021010176号       Powered by

Time of issue:2021-03-22 16:01:26

©Lanly Bioscience Technology (Suzhou) Co., Ltd.
Powered by